BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
FABP1
,
glucose metabolic process
,
Leukemia
,
Breast
,
Prozac
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Type I interferons
Summary
General Info
Curated Studies
Most Correlated Studies
Monocytes from systemic lupus erythematosus patients and healthy donors treated with IFNa2b
STAT1-deficient U3A cells transfected with IRF7 and IKKe and treated with type I interferon
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
CNS disease associated with enhanced type I interferon signalling.
Differential signaling by type-I and type-III interferons in mucosa.
Type I interferon pathway genetic variants in severe COVID-19.
Assessment of type I interferon response in routine practice in France in 2022.
Unweaving type I interferons in age-related neuroinflammation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases
Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Fai…
A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult T…
Type I Interferon Alfa-2a in Postmastectomy Breast Reconstruction
Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ